Article
The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.
Molecular psychiatry - 1 Jan 1998
Malhotra A K, Goldman D, Buchanan R W, Rooney W, Clifton A, Kosmidis M H, Breier A, Pickar D
Abstract excerpt
Several lines of evidence suggest that the dopamine D3 receptor is involved in the pathophysiology of schizophrenia. The D3 receptor gene (DRD3) contains a polymorphism resulting in a serine-glycine substitution in the N-terminus of the receptor. Shaikh and colleagues have reported a significant association between the DRD3 Ser9 allele and the Ser9/Ser9 genotype with schizophrenia in 133 Caucasians. In a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
